Primary high grade papillary serous carcinoma of cervix: report of a case

Document Type : Case Report

Authors

1 Associate Professor in Radiation Oncology, Radiotherapy Oncology Department, school of medicine, Shiraz University of Medical Sciences, Shiraz, Iran

2 Assistant Professor in radiation Oncology, Department of Radiation oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

3 Radiation Oncologist, Radiation Oncology Department, school of medicine, Shiraz University of Medical Sciences, Shiraz, Iran

4 Professor in Radiation Oncology, Colorectal Research Center, school of medicine, Shiraz, Iran

5 Assistant Professor of Dermatopathology, Department of Pathology, School of Medicine, Maternal-fetal Medicine Research Center, Shiraz University of Medical Sciences

6 Assistant Professor of Pathology, Department of Pathology, School of Medicine, Vali Asr Hospital, Fasa University of Medical Science

7 Professor in Radiation Oncology, Breast Diseases Research Center, school of medicine, Shiraz University of Medical Sciences, Shiraz, Iran

8 Professor in radiation Oncology, Department of Radiation oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

9 Breast Diseases Research Center, school of medicine, Shiraz University of Medical Sciences, Shiraz, Iran

10.30477/cjm.2022.337749.1039

Abstract

Introduction: Papillary Serous Cervical Carcinoma (PSCC) is a very rare type of primary adenocarcinoma of the cervix. Herein, we report such a case of PSCC and describe its presentation and treatment.
Case presentation:Our patient was a 65-year-old woman presented with vaginal spotting 14 years after menopause. Vaginal examination was not remarkable; however, transvaginal ultrasound showed cervical irregularity. A Pap smear was done for her that revealed atypical cells. The patient underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy. Pathologic examination and Immunohistochemical study disclosed PSCC. Metastatic evaluations including abdomen and pelvic MRI and chest CT scan were negative. Therefore, pathologic stage was IB1. Due to inadequate lymph node dissection, the patient received adjuvant external beam radiotherapy (45 Gy in 25 fractions). Subsequently, adjuvant endocavitary brachytherapy (3 fractions of 4 Gy) was delivered; however, she refused to receive any adjuvant chemotherapy. After 12 months she is well and is doing her regular daily life.
Conclusions: PSCC is a rare case and although Radiotherapy is usually done for patients, its treatment is not well known.

Keywords


  1. Khan M, Gilman AD, Nizami S, Barbaryan A, Ali AM, Mirrakhimov AE. Papillary serous carcinoma of the uterine cervix with lung metastasis. Case Rep Oncol Med. 2014;2014:683103.
  2. Jonska-Gmyrek J, Zolciak-Siwinska A, Gmyrek L, Michalski W, Poniatowska G, Fuksiewicz M, et al. Serous Carcinoma of the Uterine Cervix, an Extremely Rare Aggressive Entity: A Literature Review. Gynecol Obstet Invest. 2018;83(3):220-6.
  3. Rose PG, Reale FR. Serous papillary carcinoma of the cervix. Gynecol Oncol. 1993;50(3):361-4.
  4. Watrowski R, Striepecke E, Jager C, Bauknecht T, Horst C. Papillary-serous adenocarcinoma of the uterine cervix during tamoxifen therapy after bilateral breast cancer. Anticancer Res. 2012;32(11):5075-8.
  5. Kaplan EJ, Caputo TA, Shen PU, Sassoon RI, Soslow RA. Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case. Gynecol Oncol. 1998;70(2):289-94.
  6. Zhou C, Matisic JP, Clement PB, Hayes MM. Cytologic features of papillary serous adenocarcinoma of the uterine cervix. Cancer. 1997;81(2):98-104.
  7. Power DG, McVey GP, Delaney DW, Rea D, D'Arcy T, Daly PA, et al. Papillary serous carcinomas of the uterine cervix and paraneoplastic cerebellar degeneration: a report of two cases. Acta Oncol. 2008;47(8):1590-3.
  8. Ueda M, Koshiyama M, Yamaguchi A, Ukita S, Ukita M, Hishikawa K, et al. Advanced papillary serous carcinoma of the uterine cervix: a case with a remarkable response to paclitaxel and carboplatin combination chemotherapy. Rare Tumors. 2012;4(1):e1.
  9. Zhou C, Gilks CB, Hayes M, Clement PB. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases. Am J Surg Pathol. 1998;22(1):113-20.
  10. Togami S, Kasamatsu T, Sasajima Y, Onda T, Ishikawa M, Ikeda S, et al. Serous adenocarcinoma of the uterine cervix: a clinicopathological study of 12 cases and a review of the literature. Gynecol Obstet Invest. 2012;73(1):26-31.
  11. Kitade S, Ariyoshi K, Taguchi K, Maenohara S, Tomita Y, Sonoda K, et al. Serous carcinoma of the uterine cervix: Clinicopathological features differing from serous carcinomas of other female organs. Journal of Obstetrics and Gynaecology Research. 2020;46(1):153-60.

Articles in Press, Accepted Manuscript
Available Online from 25 September 2022
  • Receive Date: 17 April 2022
  • Revise Date: 16 July 2022
  • Accept Date: 08 August 2022
  • First Publish Date: 25 September 2022